184 related articles for article (PubMed ID: 31254482)
1. Comparison of hepatitis B virus genotypes B and C among chronically hepatitis B virus-infected patients who received nucleos(t)ide analogs: A multicenter retrospective study.
Inoue J; Akahane T; Nakayama H; Kimura O; Kobayashi T; Kisara N; Sato T; Morosawa T; Izuma M; Kakazu E; Ninomiya M; Iwata T; Takai S; Nakamura T; Sano A; Niitsuma H; Masamune A;
Hepatol Res; 2019 Nov; 49(11):1263-1274. PubMed ID: 31254482
[TBL] [Abstract][Full Text] [Related]
2. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
Rapti I; Hadziyannis S
World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
4. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK; Choi JY
J Gastroenterol Hepatol; 2014 Jan; 29(1):151-6. PubMed ID: 24117684
[TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.
Chen LP; Zhao J; Du Y; Han YF; Su T; Zhang HW; Cao GW
World J Virol; 2012 Dec; 1(6):174-83. PubMed ID: 24175223
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
McGonigal KH; Bajjoka IE; Abouljoud MS
Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810
[TBL] [Abstract][Full Text] [Related]
7. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.
Idilman R; Akyildiz M; Keskin O; Gungor G; Yilmaz TU; Kalkan C; Dayangac M; Cinar K; Balci D; Hazinedaroglu S; Tokat Y
Clin Transplant; 2016 Oct; 30(10):1216-1221. PubMed ID: 27409074
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
9. Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment.
Ando Y; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Nakano I; Hirooka Y; Goto H
Hepatol Res; 2018 Feb; 48(3):E240-E251. PubMed ID: 28865403
[TBL] [Abstract][Full Text] [Related]
10. Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients.
Wang HM; Hung CH; Lee CM; Lu SN; Wang JH; Yen YH; Kee KM; Chang KC; Tseng PL; Hu TH; Chen CH
J Gastroenterol Hepatol; 2016 Jul; 31(7):1307-14. PubMed ID: 26758501
[TBL] [Abstract][Full Text] [Related]
11. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma.
Kim SR; Kim SK
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892033
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.
Jung SK; Kim KA; Ha SY; Lee HK; Kim YD; Lee BH; Paik WH; Kim JW; Bae WK; Kim NH; Lee JS; Jwa YJ
Clin Mol Hepatol; 2015 Mar; 21(1):41-8. PubMed ID: 25834801
[TBL] [Abstract][Full Text] [Related]
14. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis.
Honda K; Seike M; Murakami K
World J Hepatol; 2015 Oct; 7(22):2404-10. PubMed ID: 26464756
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Chau A; Yeh ML; Tsai PC; Huang DQ; Kim SE; Trinh H; Yoon EL; Oh H; Jeong JY; Ahn SB; An J; Tseng CH; Hsu YC; Jeong SW; Cho YK; Shim JJ; Kim HS; Ito T; Marciano S; Kawashima K; Suzuki T; Watanabe T; Nozaki A; Ishikawa T; Inoue K; Eguchi Y; Uojima H; Abe H; Takahashi H; Chuma M; Ishigami M; Hoang JK; Maeda M; Huang CF; Gadano A; Dai CY; Huang JF; Tanaka Y; Chuang WL; Lim SG; Cheung R; Yu ML; Jun DW; Nguyen MH
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):572-580.e5. PubMed ID: 37734582
[TBL] [Abstract][Full Text] [Related]
16. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
Lampertico P; Invernizzi F; Viganò M; Loglio A; Mangia G; Facchetti F; Primignani M; Jovani M; Iavarone M; Fraquelli M; Casazza G; de Franchis R; Colombo M
J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
[TBL] [Abstract][Full Text] [Related]
17. Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma.
Baran B
World J Hepatol; 2015 Jul; 7(13):1742-54. PubMed ID: 26167247
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs.
Tsai MC; Chen CH; Hu TH; Lu SN; Lee CM; Wang JH; Hung CH
J Formos Med Assoc; 2017 Jul; 116(7):512-521. PubMed ID: 27720344
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
[TBL] [Abstract][Full Text] [Related]
20. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
